Markus Küng

651 total citations
20 papers, 489 citations indexed

About

Markus Küng is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Markus Küng has authored 20 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Markus Küng's work include Inhalation and Respiratory Drug Delivery (6 papers), Asthma and respiratory diseases (6 papers) and Respiratory and Cough-Related Research (4 papers). Markus Küng is often cited by papers focused on Inhalation and Respiratory Drug Delivery (6 papers), Asthma and respiratory diseases (6 papers) and Respiratory and Cough-Related Research (4 papers). Markus Küng collaborates with scholars based in United States, Switzerland and United Kingdom. Markus Küng's co-authors include B. E. Lütold, Fritz R. Bühler, F Burkart, Matthias Pfisterer, G A Marbet, Hans‐Peter Marti, B.A. Phillips, N. K. Burki, Graham Scott and Jose Landa and has published in prestigious journals such as Cancer, Journal of Applied Physiology and CHEST Journal.

In The Last Decade

Markus Küng

20 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Küng United States 10 158 128 126 69 64 20 489
N. Papanicolaou France 13 141 0.9× 134 1.0× 85 0.7× 119 1.7× 96 1.5× 38 547
H Fukuzaki Japan 14 431 2.7× 92 0.7× 222 1.8× 172 2.5× 74 1.2× 48 845
A Hornych France 14 174 1.1× 89 0.7× 72 0.6× 90 1.3× 73 1.1× 58 566
Yuji Hirai Japan 16 252 1.6× 84 0.7× 167 1.3× 99 1.4× 198 3.1× 23 802
J. K. McKenzie Canada 12 194 1.2× 95 0.7× 64 0.5× 173 2.5× 147 2.3× 24 586
E. Podjarny Israel 14 115 0.7× 107 0.8× 106 0.8× 71 1.0× 71 1.1× 48 707
Guo Hua Zhang China 7 282 1.8× 107 0.8× 79 0.6× 85 1.2× 116 1.8× 21 674
Frölich Jc Germany 11 78 0.5× 84 0.7× 121 1.0× 104 1.5× 56 0.9× 33 607
B. Müller‐Beckmann United States 13 296 1.9× 30 0.2× 71 0.6× 225 3.3× 69 1.1× 27 684
Takeshi Hata Japan 11 221 1.4× 51 0.4× 105 0.8× 78 1.1× 117 1.8× 45 486

Countries citing papers authored by Markus Küng

Since Specialization
Citations

This map shows the geographic impact of Markus Küng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Küng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Küng more than expected).

Fields of papers citing papers by Markus Küng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Küng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Küng. The network helps show where Markus Küng may publish in the future.

Co-authorship network of co-authors of Markus Küng

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Küng. A scholar is included among the top collaborators of Markus Küng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Küng. Markus Küng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Küng, Markus, et al.. (1998). Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis.. Journal of the American Society of Nephrology. 9(3). 397–407. 85 indexed citations
2.
Küng, Markus & L. Diamond. (1990). Adenosine-induced bronchoconstriction in human asthmatics: Effects of pretreatment with indomethacin or atropine sulfate. Pulmonary Pharmacology. 3(1). 17–23. 1 indexed citations
3.
Küng, Markus, et al.. (1989). Pulmonary Gas Exchange During Histamine-induced Bronchoconstriction in Asthmatic Subjects. CHEST Journal. 96(4). 752–756. 15 indexed citations
4.
Küng, Markus, Graham Scott, & N. K. Burki. (1989). Airways responsiveness determined by consecutive histamine challenges in asymptomatic asthmatics. Journal of Applied Physiology. 67(6). 2622–2626. 1 indexed citations
5.
Küng, Markus, et al.. (1987). Systemic Cardiovascular and Metabolic Effects Associated with the Inhalation of an Increased Dose of Albuterol. CHEST Journal. 91(3). 382–387. 41 indexed citations
6.
Batenhorst, Randal L., Alice S. Batenhorst, David A. Graves, et al.. (1986). Pharmacologic evaluation of loratadine (SCH 29851), chlorpheniramine and placebo. European Journal of Clinical Pharmacology. 31(2). 247–250. 28 indexed citations
7.
Küng, Markus. (1986). Parenteral Adrenergic Bronchodilators and Potassium. CHEST Journal. 89(3). 322–323. 12 indexed citations
8.
Scott, Graham & Markus Küng. (1985). How many spirograms for a histamine challenge?. PubMed. 132(2). 268–71. 13 indexed citations
9.
Küng, Markus, et al.. (1985). “Experimentation” with chloroform. The American Journal of Medicine. 78(4). 715–718. 9 indexed citations
10.
Küng, Markus, et al.. (1984). Benign clear cell tumor (“sugar tumor”) of the trachea. Cancer. 54(3). 517–519. 20 indexed citations
11.
Küng, Markus & L. Diamond. (1984). Effect of inhaled diphemanil methylsulfate, a parasympatholytic agent, on histamine induced bronchoconstriction in asymptomatic asthmatics.. PubMed. 52(1). 22–5. 2 indexed citations
12.
Küng, Markus, et al.. (1984). The effect of subcutaneously administered terbutaline on serum potassium in asymptomatic adult asthmatics.. PubMed. 129(2). 329–32. 24 indexed citations
13.
Küng, Markus, et al.. (1980). Modification of hypoxic pulmonary vasoconstriction by antigen challenge in sensitized sheep. Journal of Applied Physiology. 49(1). 22–27. 6 indexed citations
14.
Küng, Markus, et al.. (1979). Modification of hypoxic pulmonary vaso constriction by antigen challenge in sensitive sheep. American Review of Respiratory Disease. 2. 377. 1 indexed citations
15.
Kiowski, Wolfgang, Fritz R. Bühler, P. van Brummelen, & Markus Küng. (1979). Blunting of Exercise‐Induced Tachycardia and Renin Release 24 Hours After a Single Dose of Sotalol. The Journal of Clinical Pharmacology. 19(8-9). 513–515. 3 indexed citations
16.
Küng, Markus, et al.. (1979). Determination of pulmonary blood flow by the rebreathing technique in airflow obstruction.. PubMed. 120(3). 533–40. 8 indexed citations
17.
Küng, Markus, et al.. (1978). Pulmonary hemodynamic effects of lung inflation and graded hypoxia in conscious sheep. Journal of Applied Physiology. 45(6). 949–956. 5 indexed citations
18.
Burkart, F, Fritz R. Bühler, Matthias Pfisterer, B. E. Lütold, & Markus Küng. (1976). Haemodynamic Responses to Exercise and Acute β-Receptor Blockade in Renin Sub-Types of Essential Hypertension. Clinical Science. 51(s3). 493s–496s. 6 indexed citations
19.
Bühler, Fritz R., B. E. Lütold, Markus Küng, & Franz Koller. (1976). Once Daily Dosage Beta‐Blockade: Antihypertensive Efficacy of Slow Release Oxprenolol as Related to Renin and Age. Australian and New Zealand Journal of Medicine. 6(S3). 37–43. 8 indexed citations
20.
Bühler, Fritz R., F Burkart, B. E. Lütold, et al.. (1975). Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. The American Journal of Cardiology. 36(5). 653–669. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Papanicolaou Breakdown of academic impact, for papers by H Fukuzaki Breakdown of academic impact, for papers by A Hornych Breakdown of academic impact, for papers by Yuji Hirai Breakdown of academic impact, for papers by J. K. McKenzie Breakdown of academic impact, for papers by E. Podjarny Breakdown of academic impact, for papers by Guo Hua Zhang Breakdown of academic impact, for papers by Frölich Jc Breakdown of academic impact, for papers by B. Müller‐Beckmann Breakdown of academic impact, for papers by Takeshi Hata
Rankless by CCL
2026